Clinical trial Recruiting at 27 sites Observational Ages 16 to 50 Women only

Registry for Fetal Immune-mediated Heart Block

Official title: Slow Heart Registry: A Prospective Observational Cohort Study of Fetal Immune-mediated High Degree Heart Block

Run by The Hospital for Sick Children · NCT04559425 · Data updated 2026-11-12

This study is trying to see how different treatments for fetuses with a serious heart condition affect their health and survival as they grow up.

Quick facts

Study typeObservational
Ages16 Years to 50 Years
SexWomen only
Enrollment350 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Locations27 sites (Phoenix, Arizona and 26 other locations)
StatusRecruiting
StartedJanuary 1, 2020
Main results expectedDecember 31, 2027
Study endsDecember 31, 2029
Registry record updatedMay 22, 2024
Trial IDNCT04559425 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women whose fetuses have been diagnosed with high-degree AVB and have positive or pending anti-Ro/La antibody test results.

Probably not a fit

Patients whose AVB is associated with major congenital heart defects or who have negative anti-Ro/La antibody test results may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SLOW HEART REGISTRY is a multi-centered observational study focused on fetuses diagnosed with high-degree immune-mediated atrio-ventricular heart block (AVB). It aims to create an international database to document management strategies and outcomes for affected fetuses, comparing those treated with glucocorticoids to those who are not. The study will evaluate various clinical outcomes, including survival rates and the need for additional treatments, from diagnosis through the first few years of life. This research addresses a significant gap in prenatal care by providing evidence-based insights into the management of this condition.

Why it matters

Potential benefit: If successful, this study could improve prenatal management strategies for fetuses with immune-mediated heart block, potentially enhancing survival rates and health outcomes.

How similar studies have gone: While there is limited evidence from similar studies, this registry approach is novel and aims to fill a critical knowledge gap in the management of fetal heart block.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written informed maternal consent to participate in the Slow Heart Registry
* High-degree (2nd; 2:1; 2nd-3rd or 3rd degree) AVB diagnosed ≤ 32+0 weeks with or without hydrops
* Enrollment within maximally 8 days of high-degree AVB diagnosis
* Positive or pending anti-Ro/La antibody test results at the time of enrollment

Exclusion Criteria:

* AVB associated with major CHD (e.g. left atrial isomerism, cc-TGA)
* AVB with known negative anti-Ro and/or La antibody test result at enrollment
* 1st degree AVB
* Sinus bradycardia with normal 1:1 AV conduction
* Blocked atrial bigeminy (irregular atrial rate with failure of AV conduction of the premature atrial beat)
* Primary delivery for postnatal treatment
* Maternal-fetal conditions (other than cardiac NL) associated with high odds of premature delivery or death (e.g. renal failure, significant infectious diseases, major extracardiac anomalies, PROM, etc.)
* Preexisting maternal mental disorder (e.g. bipolar, mania, severe depression, substance abuse)
* Poorly controlled insulin-dependent diabetes (HbA1c \>7%) at CAVB diagnosis
* Oligohydramnios (deepest/maximal vertical pocket \<2 cm)
* Severe IUGR (estimated fetal weight \<3rd percentile)

Where it's running

  • Phoenix Children's Hospital
    Phoenix, Arizona, United States
    Recruiting
  • University of California San Francisco
    San Francisco, California, United States
    Recruiting
  • Children's Hospital Colorado
    Denver, Colorado, United States
    Recruiting
  • Children's National Medical Center
    Washington D.C., District of Columbia, United States
    Recruiting
  • Johns Hopkins All Children's Hospital
    St. Petersburg, Florida, United States
    Recruiting
  • Children's Mercy Kansas City
    Kansas City, Kansas, United States
    Recruiting
Show 21 more locations
  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • The Children's Heart Clinic/Children's Minnesota
    Minneapolis, Minnesota, United States
    Recruiting
  • Columbia University (New York)
    New York, New York, United States
    Recruiting
  • Texas Children's Hospital
    Houston, Texas, United States
    Recruiting
  • Seattle Children's Hospital
    Seattle, Washington, United States
    Recruiting
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting
  • National Heart Hospital
    Sofia, Bulgaria
    Recruiting
  • IWK Nova Scotia Health
    Halifax, Nova Scotia, Canada
    Recruiting
  • The Hospital for Sick Children
    Toronto, Canada
    Recruiting
  • Hospital District of Helsinki and Uusimaa
    Helsinki, Finland
    Recruiting
  • Grenoble University Hospital
    Grenoble, France
    Recruiting
  • University of Bonn
    Bonn, Germany
    Recruiting
  • Hong Kong Children's Hospital
    Ngau Tau Kok, Hong Kong
    Recruiting
  • Kanagawa Children's Medical Center
    Kanagawa, Japan
    Recruiting
  • Shizuoka Children's Hospital
    Shizuoka, Japan
    Recruiting
  • Leiden University Medical Center - LUMC
    Leiden, Netherlands
    Recruiting
  • Centre of Postgraduate Medical Education Poland
    Warsaw, Poland
    Recruiting
  • Queen Silvia Children's Hospital
    Gothenburg, Sweden
    Recruiting
  • Skane University Hospital in Lund
    Lund, Sweden
    Recruiting
  • Karolinska University Hospital, Astrid Lindgen Childrens Hospital
    Solna, Sweden
    Recruiting
  • Taiji Clinic
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Edgar Jaeggi, MD — The Hospital for Sick Children, Toronto
  • Study coordinator: Diana Balmer-Minnes, BSc, CCRP
  • Email: slow.heart@sickkids.ca
  • Phone: 416-813-7654

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.